24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Did you know? Ten unbeatable reasons to explore a career with Oxford PharmaGenesis in 2022 It’s a new year, and a time when many people reflect on whether their role is providing the opportunities, enjoyment and sense of purpose that they deserve. If this sounds familiar, and you are looking for something new, then a…
Oxford PharmaGenesis is proud to sponsor the CISCRP December 2021 Clinical Trials supplement, which raises awareness of rare diseases and neurology, and celebrates the millions of people who volunteer for clinical trials each year.
Every year during the festive season, Oxford PharmaGenesis donates to a charity aligned with our company mission to help patients in areas of unmet medical need. This year, Oxford PharmaGenesis is donating to UNICEF to help fund the delivery of more than 150 000 doses of the COVID-19 vaccines to some of the communities that…
This October, Oxford PharmaGenesis has been marking Global Diversity Awareness Month with a programme of educational and awareness-raising activities coordinated by and for our colleagues.
At Oxford PharmaGenesis, our core company values include integrity and compassion. For October’s ‘Make a Difference Day’, we asked our colleagues to share how they put these values into action in support of charities or local communities. We’re pleased to share four of our colleagues’ stories here, in recognition of their efforts to go the…
Oxford PharmaGenesis is proud to sponsor the latest clinical trials education campaign spearheaded by CISCRP (The Center for Information and Study on Clinical Research Participation) and aimed at building awareness of clinical trials among minority communities in the USA.
